Reply to Dr. Charlebois et al. (Clin Infect Dis 2002; 34:425-33) [1]

Clinical Infectious Diseases

Volumn 35, Issue 9, 2002, Pages 1135-

  Daly, P ^a   Bryce, E A ^a   Buxton, J ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL COLONIZATION; CANADA; DRUG USE; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

CANADA; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; METHICILLIN RESISTANCE; PREVALENCE; SEROTYPING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0036827520     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/342325     Document Type: Letter

References (5)

1. Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002; 34:425-33.
2. Department of Planning and Evaluation, Vancouver/Richmond Health Board. Annual Health Plan Update 1998 Appendix. Vancouver, BC: Vancouver/Richmond Health Board, 1998.
3. Schechter MT, O'Shaughnessy MV. Distribution of injection drug users in the lower mainland. BC Med J 2000; 42:80-1.
4. McLean ME. Vancouver Drug Use Epidemiology - 2001: Vancouver and BC Site Report for the Canadian Community Epidemiology Network on Drug Use. Vancouver, BC: Vancouver/Richmond Health Board, 2002.
5. Roman RS, Smith J, Walker M, et al. Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin Infect Dis 1997; 25:698-705.